News & Events about Conmed Corp.
CONMED Co. (NYSE:CNMD Get Rating) Director Brian Concannon sold 2,072 shares of the businesss stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $125.00, for a total transaction of $259,000.00. Following the sale, the director now ...
Shares of CONMED Co. (NYSE:CNMD Get Rating) have been given a consensus rating of Hold by the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have ...
CONMED (NYSE:CNMD Get Rating) and BioLife Solutions (NASDAQ:BLFS Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, ...
CONMED Co. (NYSE:CNMD Get Rating)s share price hit a new 52-week low during trading on Thursday . The stock traded as low as $71.68 and last traded at $71.68, with a volume of 2079 shares. The stock had previously closed at $75.36. CONMED Stock Performance The stock has a market cap ...
CONMED Corporation (NYSE: CNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). In...